Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2013
08/22/2013WO2013122646A2 Systems and methods for analyte detection
08/22/2013WO2013122609A1 Methods of using cdk8 antagonists
08/22/2013WO2013122470A1 Methods of differentiating hypoactive sexual desire disorder and/or female sexual arousal disorder
08/22/2013WO2013122453A1 Device and method for detection of nucleic acid(s)
08/22/2013WO2013122321A1 Use of hdac6 as hepatoma diagnosis marker and therapeutic agent
08/22/2013WO2013121383A1 Means and methods for assessing neuronal toxicity
08/22/2013WO2013121380A1 Means and methods for assessing an endocrine disease or disorder
08/22/2013WO2013121368A2 A process for detection and optional quantification of an analyte
08/22/2013WO2013121224A1 Analysis of measurements of a polymer
08/22/2013WO2013121216A1 High efficiency cell capture
08/22/2013WO2013121211A1 Micro - sensor based test apparatus
08/22/2013WO2013121202A1 Treatment of skin disorders
08/22/2013WO2013121201A1 Aptamer method
08/22/2013WO2013121193A2 Apparatus for supporting an array of layers of amphiphilic molecules and method of forming an array of layers of amphiphilic molecules
08/22/2013WO2013121170A1 Method and device for monitoring integrity of wooden posts
08/22/2013WO2013121165A1 Apparatus and method for determining an analyte in a gas sample
08/22/2013WO2013121115A1 Apparatus and method for flushing particle measurement device
08/22/2013WO2013121042A1 PP2A SUBUNITS IN DNA REPAIR, THE PP2A B55α SUBUNIT AS NOVEL PHD2 INTERACTING PROTEIN, AND IMPLICATIONS FOR CANCER
08/22/2013WO2013121038A1 Mammalian homologues of flower, their use in cancer diagnostics, prevention and treatment
08/22/2013WO2013121011A1 Method and kit for measuring interaction between molecules
08/22/2013WO2013120995A1 Exosomal biomarker for cardiovascular events in females
08/22/2013WO2013120947A1 Diagnosis of trypanosoma brucei
08/22/2013WO2013120830A1 Use of the soluble form of axl in the diagnosis and/or prognosis of heart failure syndrome
08/22/2013WO2013120191A1 Informative diagnostic kit and device for immunochromatographic detection
08/22/2013WO2013120184A1 Ingestible medical device
08/22/2013WO2013102916A4 Prediction of refining characteristics of oil
08/22/2013WO2013101983A3 Targeted self-assembly 0f functionalized carbon nanotubes on tumors
08/22/2013WO2013100745A3 Device for recovering liquid solution from the soil without power, for the automatic measurement of biochemical soil parameters
08/22/2013WO2013089819A3 Microrna mediated neuronal cell induction
08/22/2013WO2013081461A3 Methods and kits for determining protein-bound biomarkers
08/22/2013WO2013067491A9 Formation tester interval pressure transient test and apparatus
08/22/2013WO2013064830A3 Medical use
08/22/2013WO2013062261A3 Newly identified colon cancer marker and diagnostic kit using the same
08/22/2013WO2013059253A8 Process analytic instrument with multi-tube connection
08/22/2013WO2013054200A3 Methods and compositions for screening and treating developmental disorders
08/22/2013WO2012142541A8 Single molecule imaging techniques to aid crystallization
08/22/2013WO2012080747A3 Anti-ageing agents
08/22/2013US20130219529 Probe for a hair cell, and labelling method for a hair cell using the probe for a hair cell
08/22/2013US20130219527 Conditional Mst Overexpressing Construct And Conditional Myostatin Overexpressing Transgenic Mouse
08/22/2013US20130218481 Determining acid concentration by boiling point
08/22/2013US20130218477 Method for evaluating the quantity of methane produced by a dairy ruminant
08/22/2013US20130218048 Apparatus and method for determining a biochemical function of a fluid
08/22/2013US20130218034 System for quantifying blood flow in tissue and updating tissue baseline conditions
08/22/2013US20130217865 Tumor Specific Antibody
08/22/2013US20130217786 Porous nanostructures and methods involving the same
08/22/2013US20130217721 Compositions and methods for detection and treatment of b-raf inhibitor-resistant melanomas
08/22/2013US20130217707 Treating attention deficit hyperactivity disorder with nhe inhibitors
08/22/2013US20130217685 Compounds for modulating rna binding proteins and uses therefor
08/22/2013US20130217656 Methods and compositions for diagnosing and treating lupus
08/22/2013US20130217647 Biomarkers for Prostate Cancer and Methods Using the Same
08/22/2013US20130217630 Parathyroid hormone variants and assays related to disease
08/22/2013US20130217600 Methods of determining efficacy of treatments of diseases of the bowel
08/22/2013US20130217598 Microprocessor-controlled microfluidic platform for pathogen, toxin, biomarker, and chemical detection with removable updatable sensor array for food and water safety, medical, and laboratory applications
08/22/2013US20130217591 Marker Sequences for Inflammatory Prostate Diseases, Prostate Carconoma and Their Use
08/22/2013US20130217590 Methods for determining a prognosis for survival for a patient with leukaemia
08/22/2013US20130217583 Microfluidic devices and methods of use in the formation and control of nanoreactors
08/22/2013US20130217150 Assay apparatus and its control method and reaction container for assay
08/22/2013US20130217149 Competition assay
08/22/2013US20130217148 Methods Of Determining Skeletal Maturity
08/22/2013US20130217147 Detection of complexes of tau and amyloid
08/22/2013US20130217146 Virtual separation of bound and free label in a ligand assay for performing immunoassays of biological fluids, including whole blood
08/22/2013US20130217145 Antibodies which detect pivkaii and methods of use thereof
08/22/2013US20130217142 Article for biological analysis
08/22/2013US20130217140 Device for Detection of a Partial Pressure and Method for its Operation
08/22/2013US20130217138 Test element for determining a body fluid and measurement method
08/22/2013US20130217137 Systems and methods for protein melt analysis using dipyrrometheneboron difluoride compounds
08/22/2013US20130217136 Devices, methods, and test kits for electronic analyte assaying
08/22/2013US20130217135 Compound for forming fluorescent uranium complex, method for synthesizing thereof, fluorescent probe for detecting uranium and method for analyzing uranium
08/22/2013US20130217106 Biochemical analysis apparatus and rotary valve
08/22/2013US20130217064 Integrated cultivation and measurement device for label-free detection and classification of cellular alterations, in particular for generation and characterisation of cell-spheroids, components and uses thereof
08/22/2013US20130217059 Fluorescent dyes
08/22/2013US20130217054 Hybrid strip
08/22/2013US20130217053 Analyte measurement method and system with error trapping
08/22/2013US20130217050 Method for diagnosing alzheimer's disease using-soluble gpvi
08/22/2013US20130217049 Methods and Systems for Signal Amplification of Bioassays
08/22/2013US20130217048 Immunizing Compositions and Methods of Use
08/22/2013US20130217047 Kits for detecting breast or ovarian cancer in a body fluid sample and use thereof
08/22/2013US20130217045 Use of Functional Autoantibodies in Alzheimer Disease
08/22/2013US20130217044 Factor involved in latent infection with herpesvirus, and use thereof
08/22/2013US20130217043 Humanized transgenic mouse model
08/22/2013US20130217041 Detection of biological molecules by differential partitioning of enzyme substrates and products
08/22/2013US20130217038 Multiparametric method for assessing immune system status
08/22/2013US20130217037 Functionalization of gold nanoparticles with oriented proteins, application to the high-density labeling of cell membranes
08/22/2013US20130217036 New diagnostic tools for charcot-marie-tooth disease
08/22/2013US20130217034 Process for avoiding false positive results in a detecting process of an inflammation indicator in a rinse solution for taking up gingival crevicular fluid
08/22/2013US20130217032 Ligand functionalized polymers
08/22/2013US20130217031 Glyceroglycolipid antigen of mycoplasma pneumoniae
08/22/2013US20130217030 Infection prognostic assay
08/22/2013US20130217025 Chimeric dna identifier
08/22/2013US20130217021 Method for detecting and examining traumatic brain injury in vitro
08/22/2013US20130217015 Hmga2 as a biomarker for diagnosis and prognosis of ovarian cancer
08/22/2013US20130217014 Methods of using cdk8 antagonists
08/22/2013US20130217012 C-cbl mutations and uses thereof
08/22/2013US20130217011 Diagnostic biomarkers of diabetes
08/22/2013US20130217003 Method for determining an analyte content of a liquid sample by means of a bioanalyzer
08/22/2013US20130217002 Hiv-1 igg3 response in acute hiv-1
08/22/2013US20130217000 Method for characterising a biologically active biochemical element by analysing low frequency electromagnetic signals
08/22/2013US20130216999 Methods and kits for the detection of an infection in subjects with low specific antibody levels
08/22/2013US20130216998 Method for linking point of care rapid diagnostic testing results to laboratory-based methods
08/22/2013US20130216997 Methods and Systems for Detection of Microorganisms